Chris Cline | SVP, IR & Corporate Communications |
Eric Dube | CEO |
Jula Inrig | CMO |
Peter Heerma | CCO |
Laura Clague | CFO |
Bill Rote | SVP of Research & Development |
Greg Harrison | Bank of America |
Joseph Schwartz | SVB Leerink |
Maury Raycroft | Jefferies |
Michelle Gilson | Canaccord Genuity |
Liisa Bayko | Evercore ISI |
Laura Chico | Wedbush |
Good day and thank you for standing by and welcome to the Travere Therapeutics’ Fourth Quarter and Full Year 2021 Financial Results and Corporate Update. At this time, all participants’ line are in a listen-only mode. [Operator Instructions] I would now like to hand the conference over to your speaker today Mr. Chris Cline. Thank you, please go ahead.